Karin Pelka1, Matan Hofree2, Jonathan H Chen3

  • 1Broad Institute of Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, USA; Massachusetts General Hospital (MGH) Cancer Center, Harvard Medical School (HMS), Boston, MA, USA.

Cell
|August 27, 2021
PubMed
概括

不匹配修复缺陷 (MMRd) 瘤显示出比不匹配修复能力 (MMRp) 的瘤更强的抗瘤免疫力. 这项研究揭示了空间组织的免疫恶性细胞网络驱动这些多样化的癌症免疫反应.